Comparing the Cohort and Micro-Simulation Modeling Approaches in Cost-Effectiveness Modeling of Bone Conduction Implants (BCI): A Case Study of a Longitudinal Economic Analysis and a Markov Model-Based Simulation.

Author(s)

Kiesewetter K1, Dejaco T2, Scandurra F2, Rose-Eichberger K3, Hoch A2, Schwarz, Mag. C1, Urban M2
1MED-EL Medical Electronics, Innsbruck, 7, Austria, 2MED-EL Medical Electronics, Innsbruck, Austria, 3MED-EL, Innsbruck, 7, Austria

OBJECTIVES: In the field of otorhinolaryngology, health economic evaluations are widely used to assess overall short- and long-term costs associated with implantable bone conduction devices (BCIs), as well as evaluating the clinical effectiveness of such systems. While longitudinal cohort analyses follow the same group of individuals over time, generating data representing large consecutive single-center patient cohorts, Micro-simulations are mostly applied following individuals through models when data is mainly generated from systematic reviews of peer-reviewed published literature, using best practices. The objective of this study was to investigate differences in outcomes either attributed to the longitudinal economic analysis cohort modeling approach or the Markov-model based microsimulation approach.

METHODS: A decision analytic Markov-model was developed and analyzed as a Micro-simulation to estimate incremental costs and quality-adjusted life years (QALYs) of an active transcutaneous bone conduction implant (atBCI) compared to percutaneous bone conduction implants (pBCIs), following a 10-year time horizon. Costs were estimated from the perspective of National Health Service (NHS) and derived mainly from national tariff payment schemes. Results of the Micro-simulation approach were than compared to the results of the longitudinal economic analysis.

RESULTS: Results of the Micro-simulation showed total mean cumulative costs per patient of £12,562.00 for the atBCI and £12,652.00 for the pBCIs, 5-years post-implantation. Compared to the results of the longitudinal cohort analysis, total mean cumulative cost per patient (atBCI £12,453.00 vs pBCIs £12,575.00) did not differ significantly (Δ £109.00 for atBCI and Δ £77.00 for pBCIs).

CONCLUSIONS: There was little evidence that results of the Micro-simulation approach did not differ from the results of a longitudinal cohort analysis, comparing bone conduction implants within an NHS setting, when using real-world-data from systematic reviews of peer-reviewed published literature on the one hand or consecutive single-center based data on the other hand.

Conference/Value in Health Info

2022-11, ISPOR Europe 2022, Vienna, Austria

Value in Health, Volume 25, Issue 12S (December 2022)

Code

EE521

Topic

Economic Evaluation, Medical Technologies, Study Approaches

Topic Subcategory

Cost-comparison, Effectiveness, Utility, Benefit Analysis, Decision Modeling & Simulation, Literature Review & Synthesis, Medical Devices

Disease

STA: Medical Devices

Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×